International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 6 Issue 6 November-December 2024 Submit your research before last 3 days of December to publish your research paper in the issue of November-December.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 6 Issue 6
November-December 2024

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Cost Minimisation Analysis of Iv Antibiotics

Author(s) Chitra B, Abhirami Jose, Anjali M A
Country India
Abstract Antibiotic resistance is a growing concern worldwide. Minimizing the use of antibiotics is essential to slow this trend. Cost minimisation is also important, as antibiotics can be expensive. Implementing policies to encourage responsible use and developing new treatments can help reduce the need for antibiotics. By doing so, we can protect the efficacy of current antibiotics and save money in the long run. The present study focused on evaluating IV antibiotics and conducting a cost minimization analysis. The study compares the maximum and minimum prices of various branded and generic antibiotic drugs available in India using CIMS 2022 edition. The cost ratio and cost variation percentage for individual drugs were calculated and compared. The highest percentage of cost variation was seen among Gentamicin 80 mg, Meropenem 1 gm, Piperacillin + Tazobactam 4.5 gm and the lowest percentage of cost variation was seen among Vancomycin 1gm, Linezolid 600 mg and Vancomycin 500 mg. The findings indicated that the selection of appropriate antibiotics is crucial in ensuring effective cost minimization of antibiotic usage among patients.
Keywords IV Antibiotics, Cost Minimisation, Cost Ratio, Cost Variation
Field Medical / Pharmacy
Published In Volume 5, Issue 4, July-August 2023
Published On 2023-07-08
Cite This Cost Minimisation Analysis of Iv Antibiotics - Chitra B, Abhirami Jose, Anjali M A - IJFMR Volume 5, Issue 4, July-August 2023. DOI 10.36948/ijfmr.2023.v05i04.4158
DOI https://doi.org/10.36948/ijfmr.2023.v05i04.4158
Short DOI https://doi.org/gsfxpm
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 6 Isu 6Cover Page Vol 6 Isu 5Cover Page Vol 6 Isu 4

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9898-5948-55 editor@ijfmr.com